Analyst Expectations for Krystal Biotech's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published bullish opinions on Krystal Biotech (NASDAQ:KRYS) stock, with an average price target of $126.64, implying an upside from the current price of $110.64. The average price target has increased by 18.04% over the past month.
May 22, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
11 analysts have published bullish opinions on Krystal Biotech (NASDAQ:KRYS) stock, with an average price target of $126.64, implying an upside from the current price of $110.64.
The article mentions that 11 analysts have published bullish opinions on Krystal Biotech (NASDAQ:KRYS) stock over the past 3 months. The average price target of $126.64 implies an upside from the current price of $110.64. This positive sentiment from analysts is likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100